Antiretroviral treatments used among adults with HIV infection in Europe.
Saved in:
| Title: | Antiretroviral treatments used among adults with HIV infection in Europe. |
|---|---|
| Authors: | Colebunders, R., Schrooten, W., Dreezen, C., Baratta, C., Florence, E., Finazzi, R., Wilkins, E., Hemmer, R., Fleerackers, Y., Andragetti, R., Borchert, M. |
| Source: | AIDS Care. Feb2001, Vol. 13 Issue 1, p5-14. 10p. 5 Charts, 1 Graph. |
| Subjects: | HIV infections, Therapeutics, Medical centers |
| Geographic Terms: | Europe |
| Abstract: | International guidelines for the treatment of human immunodeficiency virus (HIV) infection change rapidly. They are mainly based on results from large-scale randomized clinical trials, but also on hypotheses. The objective of the study was to look at the use of antiretrovirals (ARVs) in different HIV treatment centres in Europe. Between August 1996 and September 1997 self-administered anonymous questionnaires were distributed to persons with HIV infection at inpatient and outpatient departments in 11 European countries; 1,366 people completed the questionnaire. Important differences in use of ARVs were noted between different centres. Zidovudine was the drug that was used predominantly in all countries and by 77% of all patients; the use of didanosine, zalcitabine and stavudine differed widely. Use of ARVs was found to be lower for people who reported intravenous drug use (compared to homosexual transmission), people with a low education level, and those with a monthly income lower than 992 Euro. The use of a protease inhibitor containing ARV treatment regimen was significantly lower in the centres in the south of Europe. Between 1996 and 1997, many persons with HIV infection in Europe received a suboptimal ARV treatment regimen. Use of ARVs should be improved for intravenous drug users, persons with lower educational level and lower income. [ABSTRACT FROM AUTHOR] |
| Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 3998545 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antiretroviral treatments used among adults with HIV infection in Europe. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Colebunders%2C+R%2E%22">Colebunders, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Schrooten%2C+W%2E%22">Schrooten, W.</searchLink><br /><searchLink fieldCode="AR" term="%22Dreezen%2C+C%2E%22">Dreezen, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Baratta%2C+C%2E%22">Baratta, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Florence%2C+E%2E%22">Florence, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Finazzi%2C+R%2E%22">Finazzi, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Wilkins%2C+E%2E%22">Wilkins, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Hemmer%2C+R%2E%22">Hemmer, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Fleerackers%2C+Y%2E%22">Fleerackers, Y.</searchLink><br /><searchLink fieldCode="AR" term="%22Andragetti%2C+R%2E%22">Andragetti, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Borchert%2C+M%2E%22">Borchert, M.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22AIDS+Care%22">AIDS Care</searchLink>. Feb2001, Vol. 13 Issue 1, p5-14. 10p. 5 Charts, 1 Graph. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22HIV+infections%22">HIV infections</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+centers%22">Medical centers</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Europe%22">Europe</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: International guidelines for the treatment of human immunodeficiency virus (HIV) infection change rapidly. They are mainly based on results from large-scale randomized clinical trials, but also on hypotheses. The objective of the study was to look at the use of antiretrovirals (ARVs) in different HIV treatment centres in Europe. Between August 1996 and September 1997 self-administered anonymous questionnaires were distributed to persons with HIV infection at inpatient and outpatient departments in 11 European countries; 1,366 people completed the questionnaire. Important differences in use of ARVs were noted between different centres. Zidovudine was the drug that was used predominantly in all countries and by 77% of all patients; the use of didanosine, zalcitabine and stavudine differed widely. Use of ARVs was found to be lower for people who reported intravenous drug use (compared to homosexual transmission), people with a low education level, and those with a monthly income lower than 992 Euro. The use of a protease inhibitor containing ARV treatment regimen was significantly lower in the centres in the south of Europe. Between 1996 and 1997, many persons with HIV infection in Europe received a suboptimal ARV treatment regimen. Use of ARVs should be improved for intravenous drug users, persons with lower educational level and lower income. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=3998545 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/09540120020018143 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 5 Subjects: – SubjectFull: HIV infections Type: general – SubjectFull: Therapeutics Type: general – SubjectFull: Medical centers Type: general – SubjectFull: Europe Type: general Titles: – TitleFull: Antiretroviral treatments used among adults with HIV infection in Europe. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Colebunders, R. – PersonEntity: Name: NameFull: Schrooten, W. – PersonEntity: Name: NameFull: Dreezen, C. – PersonEntity: Name: NameFull: Baratta, C. – PersonEntity: Name: NameFull: Florence, E. – PersonEntity: Name: NameFull: Finazzi, R. – PersonEntity: Name: NameFull: Wilkins, E. – PersonEntity: Name: NameFull: Hemmer, R. – PersonEntity: Name: NameFull: Fleerackers, Y. – PersonEntity: Name: NameFull: Andragetti, R. – PersonEntity: Name: NameFull: Borchert, M. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2001 Type: published Y: 2001 Identifiers: – Type: issn-print Value: 09540121 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: AIDS Care Type: main |
| ResultId | 1 |